136 related articles for article (PubMed ID: 35852510)
1. Assessment of triglyceride/glucose index with respect to coronary slow flow.
Buber I; Nar R; Kaya D; Senol H; Adali MK; Nar G
Bratisl Lek Listy; 2022; 123(8):585-588. PubMed ID: 35852510
[TBL] [Abstract][Full Text] [Related]
2. The relation between coronary flow rate, plasma endothelin-1 concentrations, and clinical characteristics in patients with normal coronary arteries.
Celebi H; Catakoglu AB; Kurtoglu H; Sener M; Hanavdelogullari R; Demiroglu C; Aytekin V; Aytekin S
Cardiovasc Revasc Med; 2008; 9(3):144-8. PubMed ID: 18606377
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the Relationship Between Triglycerides-Glucose İndex and Coronary Slow Flow: A Retrospective Case-Control Study.
Kaplangoray M; Toprak K; Başanalan F; Palice A; Aydın C; Demirkıran A; Cekici Y
Arq Bras Cardiol; 2023 May; 120(6):e20220679. PubMed ID: 37255136
[TBL] [Abstract][Full Text] [Related]
4. The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.
Zengin H; Erbay AR; Okuyucu A; Alaçam H; Yüksel S; Meriç M; Soylu K; Gedikli Ö; Murat N; Gülel O; Demircan S; Akın F; Yılmaz Ö; Şahin M
Anatol J Cardiol; 2015 Jun; 15(6):475-9. PubMed ID: 25430414
[TBL] [Abstract][Full Text] [Related]
5. Documentation of impaired coronary blood flow by TIMI frame count method in patients with atrial fibrillation.
Luo C; Wu X; Huang Z; Du Z; Hao Y; Hu C; Huang Y; Gao X
Int J Cardiol; 2013 Aug; 167(4):1176-80. PubMed ID: 22483250
[TBL] [Abstract][Full Text] [Related]
6. Coronary blood flow in patients with end-stage renal disease assessed by thrombolysis in myocardial infarction frame count method.
Sobkowicz B; Tomaszuk-Kazberuk A; Kralisz P; Malyszko J; Kalinowski M; Hryszko T; Sawicki R; Dobrzycki S; Musial WJ
Nephrol Dial Transplant; 2010 Mar; 25(3):926-30. PubMed ID: 19875377
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow.
Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M
Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833
[TBL] [Abstract][Full Text] [Related]
9. Relationship of serum salusin beta levels with coronary slow flow.
Akyüz A; Aydın F; Alpsoy Ş; Ozkaramanli Gur D; Guzel S
Anatol J Cardiol; 2019 Sep; 22(4):177-184. PubMed ID: 31584433
[TBL] [Abstract][Full Text] [Related]
10. The Spontaneous Coronary Slow-Flow Phenomenon: Reversal by Intracoronary Nicardipine.
Mehta HH; Morris M; Fischman DL; Finley JJ; Ruggiero N; Walinsky P; McCarey M; Savage MP
J Invasive Cardiol; 2019 Mar; 31(3):42-45. PubMed ID: 30555052
[TBL] [Abstract][Full Text] [Related]
11. [Plasma insulin, glucose and lipid levels, and their relations with corrected TIMI frame count in patients with slow coronary flow].
Yazici M; Demircan S; Aksakal E; Sahin M; Meriç M; Dursun I; Yüksel S; Sağkan O
Anadolu Kardiyol Derg; 2003 Sep; 3(3):222-6. PubMed ID: 12967888
[TBL] [Abstract][Full Text] [Related]
12. Aortic flow propagation velocity and neutrophil-to-lymphocyte ratio in coronary slow flow.
Ozdemi R M; Asoglu R; Aladag N; Asoglu E
Bratisl Lek Listy; 2021; 122(7):513-518. PubMed ID: 34161120
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Plasma Thrombomodulin in Patients with Coronary Slow Flow.
Wang Y; Jia PY; Chen BJ; Chen Y; Yu H; Yu Y; Yang HM; Jia DL; Ma CY
Cardiology; 2017; 138(3):141-146. PubMed ID: 28651248
[TBL] [Abstract][Full Text] [Related]
14. Thrombolysis in myocardial infarction frame count with angiographically normal coronary arteries and its relationship to ST-segment depression.
Ozdemir K; Altunkeser BB; Ozdemir A; Düzenli A
Coron Artery Dis; 2004 Jun; 15(4):205-10. PubMed ID: 15187572
[TBL] [Abstract][Full Text] [Related]
15. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
[TBL] [Abstract][Full Text] [Related]
16. Non-dipper hypertension is associated with slow coronary flow among hypertensives with normal coronary angiogram.
Aksit E; Gursul E; Aydin F; Samsa M; Ozcelik F
Cardiovasc J Afr; 2017 Jan/Feb 23; 28(1):14-18. PubMed ID: 27177043
[TBL] [Abstract][Full Text] [Related]
17. The relationship between coronary slow flow phenomenon and coronary calcium score.
Oz O; Bayram NA; Durmaz T; Keles T; Akcay M; Bozkurt E
Perfusion; 2010 Mar; 25(2):97-102. PubMed ID: 20427414
[TBL] [Abstract][Full Text] [Related]
18. Assessment of risk factors and left ventricular function in patients with slow coronary flow.
Li Y; Wang Y; Jia D; Lv Y; Zhang Y; Guan Z; Ma C
Heart Vessels; 2016 Mar; 31(3):288-97. PubMed ID: 25475386
[TBL] [Abstract][Full Text] [Related]
19. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and angiographic profile of coronary slow flow (CSF) phenomenon in North Indian population: An observational study.
Mukhopadhyay S; Kumar M; Yusuf J; Gupta VK; Tyagi S
Indian Heart J; 2018; 70(3):405-409. PubMed ID: 29961458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]